DÄ internationalArchive13/2007Bladder Cancer with Muscle Invasion

Review article

Bladder Cancer with Muscle Invasion

Dtsch Arztebl 2007; 104(13): A-868

Frohneberg, D

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

1. Wunderlich H, Wolf M, Reichelt O et al.: Radical cystectomy with ultrasound-guided partial prostatectomy for bladder cancer. Urology 2006; 68: 554–9. MEDLINE
2. Gschwend JE, Dahm P, Fair WR: Disease specific survival as endpoint of outcome for bladder cancer patients following radical cystectomy. Eur Urol 2002; 41: 440–8. MEDLINE
3. Varol C, Thalmann GN, Burkhard FC, Studer UE: Treatment of urethral recurrence following radical cystectomy and ileal bladder substitution. J Urol 2004; 172: 937–42. MEDLINE
4. Hassan JM, Cookson MS, Smith JA Jr., Chang SS: Urethral recurrence in patients following orthotopic urinary diversion. J Urol 2004; 172: 1338–41. MEDLINE
5. Simon J, Gschwend JE, Volkmer BG: Lokalrezidiv nach radikaler Zystektomie bei Harnblasenkarzinom. Der Urologe 2005; 44: 375–81. MEDLINE
6. Poulson AL, Horn T, Steven K: Radical cystektomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol 1998; 160: 2015–19. MEDLINE
7. Leissner J, Hohenfellner R, Thüroff JW, Wolf HK: Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis BJU Int 2000; 85: 817–23. MEDLINE
8. Herr H: Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy. Urology 2003; 61: 105–08. MEDLINE
9. Rodel C, Weiss C, Sauer R: Organ preservation by combined modality treatment in bladder cancer: the European perspective. Semin Radiat Oncol 2005; 15: 28–35. MEDLINE
10. Coppin CM, Gospodarowicz MK, James K et al.: Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 1996; 14: 2901–7. MEDLINE
11. Rödel C, Grabenbauer GG, Kuhn R et al.: Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. J Clin Oncol 2002; 20: 3061–71. MEDLINE
12. Nieuwenhuijzen JA, Horenblas S, Meinhardt W et al.: Salvage cystectomy after failure of interstitial radiotherapy and external beam radiotherapy in bladder cancer. BJU Int 2004; 94: 793–97. MEDLINE
13. Housset M, Maulard C, Chretien Y et al.: Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study. J Clin Oncol 1993; 11: 2150–7. MEDLINE
14. Housset M, Dufour B, Maulard-Durdux C, Chretien Y, Mejean A: Concomitant fluorouracil (5-FU)-cisplatin (CDDP) and bifractionated split course radiation therapy (BSCRT) for invasive bladder cancer. Proc Am Soc Clin Oncol 1997;16: 319a (abstract).
15. Shipley WU, Zietman AL, Kaufman DS, Coen JJ, Sandler HM: Selective bladder preservation by trimodality therapy for patients with muscularis propria-invasive bladder cancer and who are cystectomy candidates – the Massachusetts General Hospital and Radiation Therapy Oncology Group experiences. Semin Radiat Oncol 2005; 15: 36–41. MEDLINE
16. Stein JP, Lieskovsky G, Cote R et al.: Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients. J Clin Oncol 2001; 19: 666–75. MEDLINE
17. Schoborg TW, Sapolsky JL, Lewis CW Jr.: Carcinoma of the bladder treated by segmental resection. J Urol 1979; 122: 473–5. MEDLINE
18. Sweeney P, Kursh ED, Resnick MI: Partial cystectomy. Urol Clin North Am 1992; 19: 701–11. MEDLINE
19. Skinner DG, Daniels JR, Russell CA et al.: The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J Urol 1991; 145: 459–64. MEDLINE
20. Stockle M, Meyenburg W, Wellek S, Voges G, Gertenbach U, Thuroff JW, Huber C, Hohenfellner R: Advanced bladder cancer (stages pT3b, pT4a, pN1 and pN2): improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy. Results of a controlled prospective study. J Urol 1992; 148: 302–6. MEDLINE
21. Stöckle M, Wellek S, Meyenburg W et al.: Radical cystectomy with or without adjuvant polychemotherapy for non-organ-confined transitional cell carcinoma of the urinary bladder: prognostic impact on lymph node involvement. Urology 1996; 48: 868–75. MEDLINE
22. Freiha F, Reese J, Torti FM: A randomized trial of radical cystectomy versus radical cystecomty plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer. J Urol 1996; 155: 495–99. MEDLINE
23. Lehmann J, Retz M, Wiemers Ch et al.: Adjuvant cisplatin plus methotrexate versus methotrexate, vinblastine, epirubicin, and cisplatin in locally advanced bladder cancer: results of a randomized, multicenter, phase III trial (AUO-AB05/95). J Clin Oncol 2005; 23: 4963–74. MEDLINE
24. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration: Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Eur Urol 2005; 48:189–99. MEDLINE
25. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration: Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol 2005; 48: 202–5. MEDLINE